TLDR:
– Northleaf Capital Partners has successfully closed its Northleaf Growth Fund (NGF) at $212 million USD ($285 million CAD), surpassing its initial target of $200 million USD ($269 million CAD).
– The growth equity fund will focus on investing in growth-stage North American technology and healthcare companies through direct co-investments and secondary transactions.
Toronto-based investment firm Northleaf Capital Partners has announced the final close of its Northleaf Growth Fund (NGF), raising $212 million USD ($285 million CAD). The fund surpassed its initial target of $200 million USD ($269 million CAD) and will focus on growth-stage North American technology and healthcare companies through direct co-investments and secondary transactions. Northleaf plans to participate in secondary private equity due to the attractive asset class it has become in the current economic climate. Northleaf did not disclose the limited partners (LPs) participating in the fund. The firm prides itself on its proactive deal sourcing approach, which leverages its deep relationships and extensive existing portfolio to source high-conviction investment opportunities. The NGF will benefit from the extensive network and investment capabilities of Northleaf’s global platform.
